NewcelX Ltd. (NCEL)
Nasdaq: NCEL · Pharmaceutical Preparations · Zurich · filing with the SEC since 2019
Who runs NewcelX Ltd.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Twito Ronen
Chairman and CEO. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
9 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Revel Michel | CSO and Director | Mar 2026 | Apr 29, 2026 | none |
| Twito Ronen | Chairman and CEO | Mar 2026 | Mar 18, 2026 | none |
| Hagai Omri | Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
| Molakandov Kfir | VP of R&D | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Samuel Olivier | director | Mar 2026 | Apr 29, 2026 | none |
| Galili Tamar | director | Mar 2026 | Mar 18, 2026 | none |
| Iohan Eran Israel | director | Mar 2026 | Mar 18, 2026 | none |
| Oren Liora | director | Mar 2026 | Mar 18, 2026 | none |
| Zwyer Alexander | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.